Inhibition of drug transporter breast cancer resistance protein has no effect on the pharmacokinetics of major active metabolites of ozanimod

被引：0
|
作者：
Zhang, P. [1 ]
Ghosh, A. [1 ]
Thomas, M. [1 ]
Wang, X. [1 ]
Palmisano, M. [1 ]
Tran, J. [1 ]
机构：
[1] Bristol Myers Squibb Co, Princeton, NJ USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2020年 / 26卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P0343
引用
收藏
页码：285 / 285
页数：1
相关论文
共 50 条
  • [41] ABCG2 (breast cancer resistance protein/mitoxantrone associated protein) ATPase assay:: A useful tool to detect drug-transporter interactions
    Hristos Glavinas
    Emese Kis
    Akos Pal
    Rita Kovacs
    Marton Jani
    Erika Vagi
    Eva Molnar
    Szava Bansaghi
    Zoltan Kele
    Tamas Janaky
    Gyoergy Bathori
    von Richter, Oliver
    Koomen, Gerrit-Jan
    Peter Krajcsi
    DRUG METABOLISM AND DISPOSITION, 2007, 35 (09) : 1533 - 1542
  • [42] The Need for Human Breast Cancer Resistance Protein Substrate and Inhibition Evaluation in Drug Discovery and Development: Why, When, and How?
    Poirier, Agnse
    Portmann, Renee
    Cascais, Anne-Christine
    Bader, Urs
    Walter, Isabelle
    Ullah, Mohammed
    Funk, Christoph
    DRUG METABOLISM AND DISPOSITION, 2014, 42 (09) : 1466 - 1477
  • [43] Epigenetic Regulation of Multidrug Resistance Protein 1 and Breast Cancer Resistance Protein Transporters by Histone Deacetylase Inhibition
    You, Dahea
    Richardson, Jason R.
    Aleksunes, Lauren M.
    DRUG METABOLISM AND DISPOSITION, 2020, 48 (06) : 459 - 480
  • [44] Dominant-negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S-S dependent homodimerization
    Kage, K
    Tsukahara, S
    Sugiyama, T
    Asada, S
    Ishikawa, E
    Tsuruo, T
    Sugimoto, Y
    INTERNATIONAL JOURNAL OF CANCER, 2002, 97 (05) : 626 - 630
  • [45] SNAIL PROTEIN INHIBITION BY DRUG REPOSITIONING FOR RECURRENT BREAST CANCER: AN IN-SILICOSTUDY
    Benguella-Benmansour, M.
    Cherrak, S. A.
    Dali-Sahi, M.
    WORLD CANCER RESEARCH JOURNAL, 2023, 10
  • [46] P-Glycoprotein and Organic Anion Transporter Polypeptide 1B/Breast Cancer Resistance Protein Drug Transporter Activity in Pregnant Women Living With HIV
    Moreira, Fernanda de Lima
    dos Santos Melli, Patricia Pereira
    Marques, Maria Paula
    Rocha, Adriana
    Balthazar Nardotto, Glauco Henrique
    Duarte, Geraldo
    Lanchote, Vera Lucia
    JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 (02): : 219 - 227
  • [47] Involvement of the Transporters P-Glycoprotein and Breast Cancer Resistance Protein in Dermal Distribution of the Multikinase Inhibitor Regorafenib and Its Active Metabolites
    Fujita, Ken-ichi
    Masuo, Yusuke
    Yamazaki, Erina
    Shibutani, Toshiki
    Kubota, Yutaro
    Nakamichi, Noritaka
    Sasaki, Yasutsuna
    Kato, Yukio
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 106 (09) : 2632 - 2641
  • [48] Breast Cancer Resistance Protein Substrate and Inhibition Evaluation: Why, When, and How?
    Ware, Joseph A.
    Urquhart, Bradley L.
    Sugiyama, Yuichi
    Zamek-Gliszczynski, Maciej J.
    DRUG METABOLISM AND DISPOSITION, 2014, 42 (12) : 1979 - 1980
  • [49] Reversal of breast cancer resistance protein-mediated drug resistance by estrogen antagonists and agonists
    Sugimoto, Y
    Tsukahara, S
    Imai, Y
    Sugimoto, Y
    Ueda, K
    Tsuruo, T
    MOLECULAR CANCER THERAPEUTICS, 2003, 2 (01) : 105 - 112
  • [50] Genetic and Dietary Regulation of Glyburide Efflux by the Human Placental Breast Cancer Resistance Protein Transporter
    Bircsak, Kristin M.
    Gupta, Vivek
    Yuen, Poi Yu Sofia
    Gorczyca, Ludwik
    Weinberger, Barry I.
    Vetrano, Anna M.
    Aleksunes, Lauren M.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2016, 357 (01): : 103 - 113
12345